Your browser doesn't support javascript.
loading
European Society of Hypertension position paper on renal denervation 2021.
Schmieder, Roland E; Mahfoud, Felix; Mancia, Giuseppe; Azizi, Michael; Böhm, Michael; Dimitriadis, Kyriakos; Kario, Kazuomi; Kroon, Abraham A; D Lobo, Melvin; Ott, Christian; Pathak, Atul; Persu, Alexandre; Scalise, Filippo; Schlaich, Markus; Kreutz, Reinhold; Tsioufis, Costas.
Afiliação
  • Schmieder RE; University Hospital Erlangen, Department of Nephrology and Hypertension, Erlangen.
  • Mahfoud F; Department of Internal Medicine, Universitätsklinikum des Saarlandes, Saarland, University, Homburg/Saar, Germany.
  • Mancia G; University of Milano-Bicocca, Milan, Italy.
  • Azizi M; Université de Paris, INSERM, AP-HP, Hypertension Department and DMU CARTE, Hôpital Européen Georges-Pompidou Paris, France.
  • Böhm M; Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Saarland University (Kardiologie, Angiologie und Internistische Intensivmedizin), Homburg/Saar, Germany.
  • Dimitriadis K; National and Kapodistrian University of Athens, 1st Cardiology Clinic, Hippocratio Hospital, Athens, Greece.
  • Kario K; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University of Medicine, Tochigi, Japan.
  • Kroon AA; Department of Internal Medicine, Maastricht University Medical Center & Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.
  • D Lobo M; Barts NIHR Biomedical Research Centre, William Harvey Research Institute, Queen Mary University of London, London, UK.
  • Ott C; University Hospital Erlangen, Department of Nephrology and Hypertension, Erlangen.
  • Pathak A; Department of Nephrology and Hypertension, Paracelsus Medical University, Nürnberg, Germany.
  • Persu A; Department of Cardiovascular Medicine, Princess Grace Hospital, Monaco and Research Unit Toulouse University, Centre National de la Recherche Scientifique UMR 5288, Toulouse, France.
  • Scalise F; Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Schlaich M; Interventional Cardiology Department, Heart Center, Policlinico di Monza, Monza, Italy and ESH Excellence Center, Istituto Clinico Verano Brianza, Verano Brianza, Italy.
  • Kreutz R; Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, Medical Research Foundation, Faculty of Medicine, Dentistry & Health Sciences, The University of Western Australia, Perth Australia and Departments of Cardiology and Nephrology, Royal Perth Hospital, Perth, Western Austr
  • Tsioufis C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.
J Hypertens ; 39(9): 1733-1741, 2021 09 01.
Article em En | MEDLINE | ID: mdl-34261957
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Simpatectomia / Hipertensão Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Simpatectomia / Hipertensão Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article